The post INJ Price Prediction: Targeting $7.50-$8.00 by January 2025 Despite Current Oversold Conditions appeared on BitcoinEthereumNews.com. Alvin Lang Dec 03, 2025 10:04 INJ price prediction shows potential 27-35% upside to $7.50-$8.00 range within 4-6 weeks as technical indicators suggest oversold bounce from current $5.90 level. Injective Protocol (INJ) presents a compelling technical setup for a potential recovery rally as multiple analysts converge on similar price targets despite recent market weakness. With INJ trading at $5.90 after a strong 12.38% daily gain, our comprehensive Injective technical analysis suggests the token is positioning for a significant move higher. INJ Price Prediction Summary • INJ short-term target (1 week): $6.50 (+10.2%) – Breaking above Bollinger Band middle line resistance • Injective medium-term forecast (1 month): $7.50-$8.00 range (+27-35%) – Aligning with analyst consensus • Key level to break for bullish continuation: $6.58 – Critical resistance identified by multiple forecasters • Critical support if bearish: $5.19 – Major support confluence zone that must hold Recent Injective Price Predictions from Analysts The recent wave of INJ price prediction reports reveals a notably bullish consensus among cryptocurrency analysts. James Ding from Blockchain.News issued the most optimistic Injective forecast, targeting $7.75 based on oversold RSI conditions at 33.31 and positive MACD histogram signals. This aligns closely with MEXC News and Tony Kim’s shared INJ price target range of $7.50-$8.00, both citing bullish MACD divergence as a primary catalyst. While CoinLore’s more conservative $5.71 prediction stands as an outlier, the majority of analysts demonstrate medium confidence in a 20-30% upside move over the coming month. The consistency in these forecasts, particularly around the $7.50-$8.00 zone, suggests strong technical confluence at these levels. INJ Technical Analysis: Setting Up for Bullish Reversal Current Injective technical analysis reveals several compelling signals supporting our bullish INJ price prediction. The MACD histogram has turned positive at 0.0833, indicating early bullish momentum… The post INJ Price Prediction: Targeting $7.50-$8.00 by January 2025 Despite Current Oversold Conditions appeared on BitcoinEthereumNews.com. Alvin Lang Dec 03, 2025 10:04 INJ price prediction shows potential 27-35% upside to $7.50-$8.00 range within 4-6 weeks as technical indicators suggest oversold bounce from current $5.90 level. Injective Protocol (INJ) presents a compelling technical setup for a potential recovery rally as multiple analysts converge on similar price targets despite recent market weakness. With INJ trading at $5.90 after a strong 12.38% daily gain, our comprehensive Injective technical analysis suggests the token is positioning for a significant move higher. INJ Price Prediction Summary • INJ short-term target (1 week): $6.50 (+10.2%) – Breaking above Bollinger Band middle line resistance • Injective medium-term forecast (1 month): $7.50-$8.00 range (+27-35%) – Aligning with analyst consensus • Key level to break for bullish continuation: $6.58 – Critical resistance identified by multiple forecasters • Critical support if bearish: $5.19 – Major support confluence zone that must hold Recent Injective Price Predictions from Analysts The recent wave of INJ price prediction reports reveals a notably bullish consensus among cryptocurrency analysts. James Ding from Blockchain.News issued the most optimistic Injective forecast, targeting $7.75 based on oversold RSI conditions at 33.31 and positive MACD histogram signals. This aligns closely with MEXC News and Tony Kim’s shared INJ price target range of $7.50-$8.00, both citing bullish MACD divergence as a primary catalyst. While CoinLore’s more conservative $5.71 prediction stands as an outlier, the majority of analysts demonstrate medium confidence in a 20-30% upside move over the coming month. The consistency in these forecasts, particularly around the $7.50-$8.00 zone, suggests strong technical confluence at these levels. INJ Technical Analysis: Setting Up for Bullish Reversal Current Injective technical analysis reveals several compelling signals supporting our bullish INJ price prediction. The MACD histogram has turned positive at 0.0833, indicating early bullish momentum…

INJ Price Prediction: Targeting $7.50-$8.00 by January 2025 Despite Current Oversold Conditions

2025/12/05 01:07


Alvin Lang
Dec 03, 2025 10:04

INJ price prediction shows potential 27-35% upside to $7.50-$8.00 range within 4-6 weeks as technical indicators suggest oversold bounce from current $5.90 level.

Injective Protocol (INJ) presents a compelling technical setup for a potential recovery rally as multiple analysts converge on similar price targets despite recent market weakness. With INJ trading at $5.90 after a strong 12.38% daily gain, our comprehensive Injective technical analysis suggests the token is positioning for a significant move higher.

INJ Price Prediction Summary

INJ short-term target (1 week): $6.50 (+10.2%) – Breaking above Bollinger Band middle line resistance
Injective medium-term forecast (1 month): $7.50-$8.00 range (+27-35%) – Aligning with analyst consensus
Key level to break for bullish continuation: $6.58 – Critical resistance identified by multiple forecasters
Critical support if bearish: $5.19 – Major support confluence zone that must hold

Recent Injective Price Predictions from Analysts

The recent wave of INJ price prediction reports reveals a notably bullish consensus among cryptocurrency analysts. James Ding from Blockchain.News issued the most optimistic Injective forecast, targeting $7.75 based on oversold RSI conditions at 33.31 and positive MACD histogram signals. This aligns closely with MEXC News and Tony Kim’s shared INJ price target range of $7.50-$8.00, both citing bullish MACD divergence as a primary catalyst.

While CoinLore’s more conservative $5.71 prediction stands as an outlier, the majority of analysts demonstrate medium confidence in a 20-30% upside move over the coming month. The consistency in these forecasts, particularly around the $7.50-$8.00 zone, suggests strong technical confluence at these levels.

INJ Technical Analysis: Setting Up for Bullish Reversal

Current Injective technical analysis reveals several compelling signals supporting our bullish INJ price prediction. The MACD histogram has turned positive at 0.0833, indicating early bullish momentum despite the overall MACD remaining negative at -0.4667. This divergence often precedes significant price reversals.

INJ’s position within the Bollinger Bands at 0.4445 suggests the token is approaching oversold territory without reaching extreme levels, providing room for upward movement toward the upper band at $6.88. The RSI at 43.48 sits in neutral territory, offering flexibility for either direction but showing no immediate overbought concerns.

Volume analysis from Binance spot trading shows $7.7 million in 24-hour volume, supporting the recent 12.38% price surge and suggesting genuine buying interest rather than low-volume manipulation.

Injective Price Targets: Bull and Bear Scenarios

Bullish Case for INJ

Our primary INJ price target of $7.50-$8.00 represents a logical extension of the current technical setup. The immediate path requires breaking above the critical $6.58 resistance level, which coincides with the 20-period SMA at $6.00 and Bollinger Band middle line.

Successfully clearing $6.58 would likely trigger momentum toward $7.34 (immediate resistance) before targeting the analyst consensus zone. The 50-period SMA at $7.16 provides additional confluence for this Injective forecast, while the $8.00 level represents a 61.8% Fibonacci retracement from the recent decline.

Bearish Risk for Injective

The primary risk to our bullish INJ price prediction centers on the $5.19 support level identified by Lawrence Jengar. A breakdown below this critical zone would invalidate the current recovery narrative and potentially target the 52-week low near $5.21.

Additional bearish signals would include MACD histogram turning negative again or RSI falling below 35, suggesting renewed selling pressure. The significant distance from the 200-period SMA at $11.38 also highlights the longer-term bearish context that could reassert itself.

Should You Buy INJ Now? Entry Strategy

Based on our Injective technical analysis, the current $5.90 level presents a reasonable entry opportunity for those asking whether to buy or sell INJ. However, a more conservative approach would involve waiting for a pullback to the $5.50-$5.60 range, which offers better risk-reward dynamics.

For immediate entries, implement a stop-loss below $5.19 (the critical support level) to limit downside risk to approximately 12%. Position sizing should reflect the medium confidence level of this prediction, with 1-2% portfolio allocation being appropriate for most investors.

Consider scaling into positions by purchasing 50% of intended allocation immediately and reserving remaining capital for potential dips toward the $5.50 support zone.

INJ Price Prediction Conclusion

Our comprehensive analysis supports a bullish Injective forecast targeting the $7.50-$8.00 range within 4-6 weeks, representing potential gains of 27-35% from current levels. This INJ price prediction carries medium confidence based on converging analyst targets and improving technical momentum.

Key indicators to monitor for confirmation include MACD crossing above zero, RSI maintaining above 45, and most critically, price breaking above the $6.58 resistance level. Invalidation would occur on a break below $5.19 support.

The timeline for this prediction extends through January 2025, with initial targets around $6.50 achievable within one week if current momentum continues. Traders should prepare for volatility given INJ’s elevated ATR of $0.60, but the technical setup suggests the path of least resistance points higher for Injective Protocol.

Image source: Shutterstock

Source: https://blockchain.news/news/20251203-price-prediction-inj-targeting-750-800-by-january-2025

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
SEC Approves Decision Concerning Bitcoin and 9 Altcoins – The Dow Jones of Cryptocurrencies May Have Arrived

SEC Approves Decision Concerning Bitcoin and 9 Altcoins – The Dow Jones of Cryptocurrencies May Have Arrived

The post SEC Approves Decision Concerning Bitcoin and 9 Altcoins – The Dow Jones of Cryptocurrencies May Have Arrived appeared on BitcoinEthereumNews.com. While the cryptocurrency market doesn’t yet have a comprehensive index like the Dow Jones or S&P 500, Bitwise is one step closer to filling this void. The company’s new exchange-traded product, Bitwise 10 Crypto Index ETF (BITW), has begun trading, offering individual investors and financial advisors access to the 10 largest crypto assets in a single product. BITW’s portfolio includes the following digital assets: Bitcoin, Ethereum, XRP, Solana, Chainlink, Litecoin, Cardano, Avalanche, Sui, and Polkadot. Bitwise CEO and co-founder Hunter Horsley told CNBC that this conversion makes the company the first to include altcoins like Cardano, Avalanche, Sui, and Polkadot, which don’t currently have spot ETFs, in an ETF from a major asset manager. “This step significantly broadens the investor base that can access various crypto assets,” Horsley said. “This is particularly important for assets without a spot ETF.” According to the CEO, this ETF also provides significant accessibility for smaller investors who invest through individual retirement accounts (IRAs) or pension funds and are only able to access ETFs. BITW, previously an index fund containing the same assets, has been converted to an ETF and is now listed on the stock exchange with $1.5 billion in assets under management. The ETF structure provides additional benefits to investors by offering greater trading flexibility, tax advantages, and lower costs, along with broader trading permissions. This development follows an expanded wave of ETFs that followed the U.S. Securities and Exchange Commission (SEC) approval of spot Bitcoin ETFs in January 2024. Since then, asset managers have sought approval for a wider range of ETFs, from altcoins like Sui and Aptos to Trump-themed tokens and memecoins like Dogecoin. However, as the market matures, crypto assets are beginning to take on their own dynamics, suggesting that broad-based products like BITW could offer a diversification tool similar…
Share
BitcoinEthereumNews2025/12/10 06:40